
LCRF News: April 2022

April is National Minority Cancer Awareness Month
LCRF is hosting several special webinars in April, so register to attend and share with others who may be interested:
April 20 – Minorities & Lung Cancer/Addressing Health Disparities with Dr. Loretta Erhunmwunsee
April 25 – Vivir con Diagnóstico de Cáncer de Pulmón: A Spanish-language webinar with Dr. Edgardo S. Santos
April 27 – Lung Cancer & Lung Cancer Screening: A Cantonese-language webinar with Dr. Rex H. Wu, in partnership with New York Presbyterian-Weill Cornell Medical Center
See all events and register at
To view LCRF’s resources for Black Americans featuring the story of Olympic gold-medalist, Jesse Owens, visit LCRF.org/KnowYourRisk:
- View and share the
documentary video Download or order the Guidebook “Breathe Easy: Good News About Lung Cancer Screening – A Guide for Black Americans”- View and share
the PSAs
#TogetherSeparately Monthly Livestreams & Facebook Group
LCRF hosts webinars to bring the lung cancer community together to discuss topics important to them.
Patient-powered research partnership announcement:
LCRF and ALK Positive announced a research partnership to fund ALK-positive related lung cancer projects. Together, they pledge to fund three grants totaling $750,000 to advance high-impact research that potentially will ultimately transform care and improve outcomes for patients with ALK-positive non-small cell lung cancer (NSCLC).
LCRF Research Grant Requests for Proposals announcement:
LCRF’s annual research grant Requests for Proposals are now open for project submission. In addition to its long-standing request for Pilot Grant proposals, LCRF has added three new grant tracks in 2022 aimed at furthering its commitment to funding investigators who are dedicated to finding solutions to the most pressing issues in lung cancer, including: early detection, gaining an understanding of and finding new approaches to treat specific molecular subsets of lung cancer and addressing inequities in the careers of investigators from underrepresented groups in cancer research. To apply, visit
To read the